| Incivek (telaprevir) / J&J, Vertex, Mitsubishi Tanabe |
2011-005636-26: Study about human defence for chronic hepatitis C in patients who will be treated with telaprevir with peginterferon-alfa and ribavirin |
|
|
| Ongoing | 4 | 25 | Europe | Incivo, Incivo | Foundation for Liver Research, Janssen-Cilag | Chronic hepatitis C | | | | |
2012-005525-75: Peg-IFN, RBV and telaprevir vs Peg-IFN and RBV alone in patients with acute hepatitis C and HIV co-infection |
|
|
| Ongoing | 3 | 20 | Europe | Incivo (telaprevir), Incivo, Incivo | St Stephen\'s AIDS Trust, St Stephen's AIDS Trust | Acute hepatitis C infection | | | | |
| Ongoing | 2 | 16 | Europe | Film-coated tablet, Incivo, Paroxetine Sandoz | Radboud University Nijmegen Medical Centre, Janssen Cilag | chronic hepatitis C infection with depression, chronic hepatitis C infection with depression, Diseases [C] - Virus Diseases [C02] | | | | |
2010-021156-26: A Phase 1, Randomized, Open-label, Single-Dose, Crossover, Relative Bioavailability, and Food-Effect Study of a Pediatric Chewable Tablet Formulation Relative to a 375-mg Core Tablet Formulation of Telaprevir in Healthy Adult Subjects |
|
|
| | 1 | | NA | telaprevir, VX-950, | Vertex Pharmaceuticals Inc., Vertex Pharmaceuticals Inc. | chronic hepatitis c virus genotype 1 infection | | | | |
| No Longer Available | N/A | | Europe, RoW | Telaprevir + peginterferon alfa + ribavirin, experimental, peginterferon alfa + ribavirin | Janssen-Cilag International NV | Hepatitis C | | | | |
|
|
|
|
|
|
|
|
|